Abstract
We performed combination chemotherapy in the outpatient clinic on a 47-year-old man with nonresected gastric cancer accompanied by peritoneal dissemination. At first we administered S-1/DOC combination chemotherapy. Afterwards a rise of tumor marker (CEA) occurred accompanying taste disorder and edema of the lower limbs, so we changed to combination chemotherapy for PTX/CDDP. Since the only side effect was numbness, the patient was treated on an outpatient basis while working. The case achieved good QOL by these combination chemotherapy methods for 1 year 10 months post exploratory laparotomy.
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / pathology
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cisplatin / administration & dosage
-
Docetaxel
-
Drug Combinations
-
Humans
-
Male
-
Middle Aged
-
Oxonic Acid / administration & dosage
-
Paclitaxel / administration & dosage
-
Peritoneum / pathology
-
Quality of Life
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / pathology
-
Taxoids / administration & dosage
-
Tegafur / administration & dosage
-
Treatment Outcome
Substances
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents
-
Antineoplastic Agents, Phytogenic
-
Drug Combinations
-
Taxoids
-
S 1 (combination)
-
Tegafur
-
Docetaxel
-
Oxonic Acid
-
Paclitaxel
-
Cisplatin